FDA social media posts on COVID under legal, medical scrutiny for misleading claims

The FDA’s Twitter habits are getting scrutiny in court and from medical professionals as the feds seesaw between walking back their once-confident COVID-19 assertions and making sweeping new claims without providing evidence.

Having long ago conceded that COVID vaccines can’t stop viral transmission and that assertions to the contrary by President Biden among others were based on “hope” rather than science, the feds are now downplaying the influence of their social media to escape liability for allegedly violating statutory limits by interfering in medical judgments.

At the same time, over the past two months, FDA Commissioner Robert Califf has gone on a spree of evidence-free tweets about bivalent boosters and oral antivirals, such as Pfizer’s rebound infection-prone Paxlovid, prompting exasperation from leading doctors.

The FDA’s “social media statements … are what bother me the most,” U.S. District Judge Jeffrey Brown said in a hearing this month on the government’s motion to dismiss a lawsuit by three doctors who claim the agency’s false portrayals of ivermectin have harmed their ability to treat patients and threatened their licenses.

Keep reading

FDA Says Telling People Not to Take Ivermectin for COVID-19 Was Just a Recommendation

The U.S. Food and Drug Administration (FDA) telling people to “stop” taking ivermectin for COVID-19 was informal and just a recommendation, government lawyers argued during a recent hearing.

“The cited statements were not directives. They were not mandatory. They were recommendations. They said what parties should do. They said, for example, why you should not take ivermectin to treat COVID-19. They did not say you may not do it, you must not do it. They did not say it’s prohibited or it’s unlawful. They also did not say that doctors may not prescribe ivermectin,” Isaac Belfer, one of the lawyers, told the court during the Nov. 1 hearing in federal court in Texas.

“They use informal language, that is true,” he also said, adding that, “it’s conversational but not mandatory.”

The hearing was held in a case brought by three doctors who say the FDA illegally interfered with their ability to prescribe medicine to their patients when it issued statements on ivermectin, an anti-parasitic that has shown positive results in some trials against COVID-19.

Ivermectin is approved by the FDA but not for COVID-19. Drugs are commonly used for non-approved purposes in the United States; the practice is known as off-label treatment.

The FDA created a webpage in 2021 titled “Why You Should Not Use Ivermectin to Treat or Prevent COVID-19” and later posted a link to the page on Twitter while writing: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.” A second post stated: “Hold your horses, y’all. Ivermectin may be trending, but it still isn’t authorized or approved to treat COVID-19.”

In a separate page, the FDA said: “Q: Should I take ivermectin to prevent or treat COVID-19? A: No.”

Those actions interfered with the doctors’ practice of medicine, violating the laws including the Federal Food, Drug, and Cosmetic Act, the lawsuit alleges.

Keep reading

FDA Announces LAB GROWN MEAT That Was Served at COP27 Climate Conference Is ‘SAFE TO EAT’: ‘The World Is Experiencing A Food Revolution’

The US Food and Drug Administration has approved lab-grown meat, a product grown from animal cells, for human consumption for the first time.

The FDA announced Wednesday that laboratory-grown chicken developed by Upside Food, is “safe to eat,” clearing the way for the California-based company that creates cell-cultured chickens to begin selling its products.

To manufacture its meat, Upside Foods harvests cells from live animals, chicken tissue, and uses the cells to grow meat in stainless-steel tanks known as bioreactors.

The agency issued a statement Wednesday announcing it evaluated Upside Food’s production and cultured cell material and has “no further questions” about the safety of its cultivated chicken filet.

“The world is experiencing a food revolution,” stated FDA Commissioner Robert M. Califf. “Advancements in cell culture technology are enabling food developers to use animal cells obtained from livestock poultry, and seafood in the production of food with these products expected to be ready for the US market in the near future.”

“The FDA’s goal is to support innovation in food technologies while always maintaining as our first priority the safety of the foods available to US consumers,” he added.

Upside Foods founder and CEO Uma Valeti heralded the FDA’s approval.

“I’ve been looking forward to this day for a long time. UPSIDE has received our “No Question Letter” from the FDA. They’ve accepted our conclusion that cultivated chicken is safe to eat, meaning UPSIDE is one step closer to being on tables,” Valeti tweeted.

Keep reading

FDA Withholds Autopsy Results of Those Who Died After COVID Shots

The U.S. Food and Drug Administration (FDA) has refused a Freedom of Information Act (FOIA) request to release the autopsy results of people whose deaths were reported to the Vaccine Adverse Event Reporting System (VAERS) after receiving a COVID-19 shot. The FOIA request was submitted by The Epoch Times newspaper.1

“VAERS is a centralized vaccine reaction reporting system that was among the safety provisions secured by parents of DPT (diphtheria-pertussis-tetanus) vaccine injured children in the National Childhood Vaccine Injury Act (NCVIA) of 1986,” explains Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center (NVIC). It is jointly operated by the FDA and U.S. Centers for Disease Control and Prevention (CDC).2 3

According to The Epoch Times, the FDA declined to release any autopsy reports of VAERS deaths, even redacted copies, citing FOIA section (8) (A) which allows federal agencies to withhold information from the public if an agency “reasonably foresees that disclosure would harm an interest protected by an exemption,” with the exemption being “personnel and medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Keep reading

Smoking gun? FDA refusing to provide key covid “vaccine” safety analyses, suggesting massive coverup

Government regulators at the U.S. Food and Drug Administration (FDA) say they will not release any of the agency’s Covid-19 “vaccine” safety analyses for independent review because their findings are allegedly part of internal discussions that are protected by law.

Back in July, The Epoch Times submitted a request to the FDA for all analyses performed using a special method called Empirical Bayesian data mining. This method involves comparing adverse events recorded after injection with a Fauci Flu shot to adverse events recorded after injection with some other non-covid vaccine.

Whatever data these analyses produced was used by the FDA to foist Chinese Virus shots on everyone, including infants and toddlers. (Related: Check out our earlier coverage about the FDA’s suspicious secrecy to learn more.)

The operational procedures laid out by the agency and its partner in January 2021 and February 2022 stipulate that the FDA is to perform data mining “at least biweekly,” if not more often than that, to identify adverse events “reported more frequently than expected following vaccination with COVID-19 vaccines.” That data was to come from the official Vaccine Adverse Event Reporting System (VAERS).

Keep reading

FDA to Authorize New COVID Booster for Omicron – But No Human Trials, Only Mice

The ‘Emergency Use Authorization’ canard seems to be the key tool which Big Pharma and Big Government use to run their confidence trick on a largely unsuspecting public. More fast-tracked ‘testing’ means more mass experimentation on the general population.

When it comes to the vaccine business, the hundreds of millions spent by industry lobbyists continues to pay massive dividends. Despite the fact that there is no discernible COVID-19 ‘pandemic’ anywhere, operatives embedded in corrupt institutions like the FDA are continuing to push the false premise that the world in stuck in a perpetual state of emergency, thereby justifying any and every half-baked measure and legal loophole – all designed to push products which are either being subsidized or directly purchased by government. That’s why business is still booming.

So let the ‘game of variants’ begin again.

It’s the same oil script being trotted out by the usual suspects…

Keep reading

FDA Can’t Stop Harassing Distillers Who Made Hand Sanitizer During the Pandemic

One year ago, when distiller Aaron Bergh of Calwise Spirits in Paso Robles, California, donated the last of the hand sanitizer he had produced to address shortages during the early days of the COVID pandemic, he assumed that this unexpected detour in the life of his small business was behind him. Then, in June, he received an unexpected letter from the Food and Drug Administration (FDA) informing him that a sample of his sanitizer taken in December 2020 exceeded temporary limits of two impurities and demanding extensive records of his production and distribution.

Bergh isn’t the only one. Rebecca Harris, president of the American Craft Spirits Association, says that at least 11 distillers in nine states have received similar letters from the FDA. At primary issue is acetaldehyde, a chemical that occurs naturally in fruits and dairy products, as well as in beer, wine, and spirits. The FDA sets limits on its presence in hand sanitizer at 50 parts per million (ppm). The sample from Bergh’s distillery tested at 160 ppm and 167 ppm of acetaldehyde and acetal, respectively.

There are valid reasons to limit levels of acetaldehyde in hand sanitizer. The chemical is a potential irritant and is considered a known carcinogen. Yet, it’s also one that most of us consume on a regular basis due to its natural occurrence in many foods and drinks; it’s also produced in our bodies whenever we have an alcoholic beverage as part of the process of breaking down ethanol. If you’ve enjoyed a banana or a beer recently, you’ve consumed acetaldehyde. As with any potentially toxic substance, the risks vary with the level and route of exposure.

The new round of letters from the FDA raises two questions. The first is whether the levels of acetaldehyde in sanitizer produced by distillers rises to levels where they pose a real risk to users. The second is, if there is a genuine risk, why has the agency waited more than 18 months after taking samples to begin acting on the test results, long after the sanitizer was distributed to health care workers and consumers?

Keep reading

Not Even the FDA Trusts the FDA To Regulate Food Safety

Last week, the Food and Drug Administration (FDA) announced the agency has sought an external review of its approach to food safety. The surprising announcement, issued by FDA commissioner Dr. Robert Califf, says the review will look primarily at work carried out by the FDA’s Office of Food Response and Policy (OFPR) and Center for Food Safety and Applied Nutrition (CFSAN).

In his announcement, Califf stresses that America’s food supply is safe. But he also notes issues with the agency’s food-safety inspection regime and says “the increasing diversity and complexity of the nation’s food systems and supply chain” have raised fundamental “questions about the structure, function, funding[,] and leadership” of the FDA.

As PoliticoThe New York Times, and others have reported, the external FDA review comes as the agency is hammered for its role in an ongoing shortage of baby formula. But suggestions that this review is all (or even largely) about baby food are likely off base. Consider that Califf’s announcement didn’t mention baby formula. What’s more, the it’s-the-baby-formula crowd suffers from recency bias. In fact, there’s no shortage of non-formula reasons why the FDA’s food-safety oversight is in critics’ crosshairs.

Last year, for example, the FDA celebrated the ten-year anniversary of the Food Safety Modernization Act (FSMA), which the agency and many of the law’s supporters have touted as the most extensive, impactful, and important overhaul of the FDA’s food-safety authority in more than 75 years. It’s not. As I noted in a column marking FSMA’s first (and hopefully last) decade, CDC estimates of the number of annual cases of foodborne illness in America have remained unchanged in the wake of FSMA’s passage and implementation.

Keep reading

‘Like a Horror Movie’: Top Scientists Alarmed and Embarrassed by Agencies’ Failure to Follow Science on COVID

Top doctors and scientists at the leading U.S. public health agencies are “frustrated, exasperated and alarmed” about the direction of the agencies they work for, according to the authors of a Substack post published last week.

They’re also embarrassed — about “bad science.” And many are leaving.

“It’s like a horror movie I’m being forced to watch and I can’t close my eyes,” said one senior official with the U.S. Food and Drug Administration (FDA). “People are getting bad advice and we can’t say anything.”

The comment was one of many culled from calls and text messages between officials and the article’s co-authors, Marty Makary M.D., M.P.H., and Tracy Beth Høeg M.D., Ph.D.

Makary and Høeg said the officials who spoke to them agreed to be quoted — but only anonymously, for fear of professional repercussions.

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are plagued with “low morale” and “high turnover,” officials told Makary and Høeg.

“At the NIH, doctors and scientists complain to us about low morale and lower staffing: The NIH’s Vaccine Research Center has had many of its senior scientists leave over the last year, including the director, deputy director and chief medical officer,” they wrote.

And it’s no better at the CDC, they said:

“The CDC has experienced a similar exodus. ‘There’s been a large amount of turnover. Morale is low,’ one high-level official at the CDC told us. ‘Things have become so political, so what are we there for?’ Another CDC scientist told us: ‘I used to be proud to tell people I work at the CDC. Now I’m embarrassed.’”

Officials complained the heads of their agencies “are using weak or flawed data to make critically important public health decisions, that such decisions are being driven by what’s politically palatable to people in Washington or to the Biden administration and that they have a myopic focus on one virus instead of overall health.”

One CDC scientist told Makary and Høeg about the shame and frustration within the agency over what happened to U.S. children during the pandemic.

The scientist said:

“CDC failed to balance the risks of COVID with other risks that come from closing schools. Learning loss, mental health exacerbations were obvious early on and those worsened as the guidance insisted on keeping schools virtual. CDC guidance worsened racial equity for generations to come. It failed this generation of children.”

The CDC also ignored natural immunity, according to some officials who declined to be named. “The vast majority of children have already had COVID, but this has made no difference in the blanket mandates for childhood vaccines.”

By mandating “vaccines and boosters for young healthy people, with no strong supporting data, these agencies are only further eroding public trust,” they added.

“I can’t tell you how many people at the FDA have told me, ‘I don’t like any of this, but I just need to make it to my retirement,’” one official told Makary and Høeg.

Keep reading

FDA-Approved Brain Computer Interface Company “Synchron” Implants First Brain Device in US Patient

New York-based Synchron, the startup behind an FDA ‘breakthrough neuroprosthesis device,’ successfully implanted its first brain device in a patient in the US earlier this month, Bloomberg first reported.

According to the news outlet, a doctor at Mount Sinai West Medical Center in New York inserted a “1.5-inch-long implant consisting of wires and electrodes into a blood vessel in the brain of an ALS patient” on July 6.

In August 2020, Synchron becomes the first brain-computer interface (BCI) company to receive the FDA’s approval to conduct an investigational device exemption (IDE) clinical trial of a permanently implanted device.

NIH awarded Synchron $10 million to begin a US trial of a brain implant that allows users to manage digital apps using only their thoughts, as reported by Fierce Biotech.

“Our neuroprosthetics are designed to help people get their lives back by restoring lost functions,” Synchron wrote on its website.

Keep reading